D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Stantec
STN
$7.69B
| $7.3M | 0.01% |
262,800
+26,900
| +11% | +$714K |
|
|
CSGS
1102
DELISTED
CSG Systems International
CSGS
| $7.27M | 0.01% |
181,376
-9,419
| -5% | -$372K |
|
1103
Alpha and Omega Semiconductor
AOSL
$923M
| $7.25M | 0.01% |
439,558
+5,283
| +1% | +$86.5K |
|
1104
PUT
Alaska Air
ALK
$5.15B
| $7.25M | 0.01% |
95,000
+85,000
| +850% | +$6.95M |
|
1105
Bath & Body Works
BBWI
$4.01B
| $7.23M | 0.01% |
214,942
+157,131
| +272% | +$5.27M |
|
1106
Integra LifeSciences
IART
$1.54B
| $7.22M | 0.01% |
143,132
-119,690
| -46% | -$6.15M |
|
1107
Matrix Service
MTRX
$347M
| $7.22M | 0.01% |
475,329
-46,104
| -9% | -$524K |
|
1108
Jabil
JBL
$32.8B
| $7.22M | 0.01% |
+252,880
| New | +$7.65M |
|
1109
Encore Capital Group
ECPG
$1.93B
| $7.22M | 0.01% |
162,916
-10,374
| -6% | -$420K |
|
1110
PUT
Range Resources
RRC
$9.11B
| $7.21M | 0.01% |
368,400
+45,000
| +14% | +$870K |
|
|
OME
1111
DELISTED
Omega Protein
OME
| $7.2M | 0.01% |
432,476
+27,747
| +7% | +$451K |
|
|
KITE
1112
PUT
DELISTED
Kite Pharma, Inc.
KITE
| $7.19M | 0.01% |
+40,000
| New | +$5.57M |
|
1113
PUT
3M
MMM
$89B
| $7.18M | 0.01% |
40,903
-25,236
| -38% | -$4.37M |
|
1114
iShares National Muni Bond ETF
MUB
$45.1B
| $7.17M | 0.01% |
64,700
| – | – |
|
|
ALOG
1115
DELISTED
Analogic Corp
ALOG
| $7.16M | 0.01% |
85,543
-10,700
| -11% | -$780K |
|
|
COHR
1116
PUT
DELISTED
Coherent Inc
COHR
| $7.15M | 0.01% |
30,400
-11,300
| -27% | -$2.73M |
|
|
RDS.A
1117
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $7.14M | 0.01% |
117,878
+112,118
| +1,946% | +$6.27M |
|
1118
ATI
ATI
$27B
| $7.13M | 0.01% |
298,259
-125,096
| -30% | -$2.47M |
|
1119
Grupo Cibest SA
CIB
$20.4B
| $7.13M | 0.01% |
155,599
-45,698
| -23% | -$2.06M |
|
1120
Principal Financial Group
PFG
$23.6B
| $7.11M | 0.01% |
110,473
+60,092
| +119% | +$3.87M |
|
|
GG
1121
PUT
DELISTED
Goldcorp Inc
GG
| $7.09M | 0.01% |
547,000
-33,900
| -6% | -$446K |
|
1122
PUT
Chemours
CC
$2.59B
| $7.08M | 0.01% |
140,000
+30,000
| +27% | +$1.42M |
|
1123
HUB Group
HUBG
$3.01B
| $7.08M | 0.01% |
329,910
-125,872
| -28% | -$2.4M |
|
1124
G-III Apparel Group
GIII
$1.47B
| $7.07M | 0.01% |
243,527
-79,187
| -25% | -$2.09M |
|
|
KITE
1125
DELISTED
Kite Pharma, Inc.
KITE
| $7.03M | 0.01% |
+39,106
| New | +$5.45M |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.